Literature DB >> 10599052

Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats.

X A Alvarez1, C Sampedro, R Lozano, R Cacabelos.   

Abstract

Citicoline is an endogenous intermediate involved in the biosynthesis of brain phospholipids and acetylcholine which has been extensively used for the treatment of several neurodegenerative conditions. The effects of citicoline on neurodegeneration, apoptosis and learning were investigated in male Sprague Dawley rats subjected to implants of the beta-amyloid fragment 1-40 (A beta 4: 3 Mmol) into the right hippocampus and to permanent unilateral occlusion of the carotid artery. Citicoline (CDP; 0, 62.5, 125 and 250 mg/kg/day i.p.) was given during 2 days before and for 5 days after surgery, and the extension of the degeneration and the number of apoptotic figures (TUNEL technique) were evaluated in the dentate gyrus (DG) and the CA1 area of the hippocampus. Citicoline, at 125 and 250 mg/kg, reduced the number of apoptotic neurons in the hippocampus of rats with A beta 4/hypoperfusion-induced neurodegeneration (CDP0 = 105.3 +/- 32.8 apoptotic figures; CDP125 = 39.2 +/- 7.4** apoptotic figures; CDP250 = 34.5 +/- 14.4** apoptotic figures; **p < 0.01 vs. CDP0). CDP also reduced neuronal degeneration in the CA1 area in a dose-dependent manner (CDP0 = 450.5 +/- 130.1 microns; CDP62.5 = 280.6 +/- 76.3 microns; CDP125 = 86.6 +/- 37.3* microns; CDP250 = 121.7 +/- 85.3* microns; p < 0.05 vs. CDP0). Variability of results was very high in the DG, where a significant reduction in the extent of neurodegeneration was only observed in the group of rats receiving 62.5 mg/kg of citicoline. Finally, citicoline improved retention of a passive avoidance learning task, increasing the number of avoidances (Av) (CDP0 = 4.2 +/- 0.7 Av; CDP62.5 = 6.9 +/- 1.0 Av; CDP125 = 7.9 +/- 0.7** Av; CDP250 = 8.5 +/- 0.6** Av; **p < 0.01 vs. CDP0) in a dose-related manner. Based on these results, it was concluded that citicoline exerts antiapoptotic, neuroprotective and antiamnesic effects in conditions of neurodegeneration induced by A beta 4 plus hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10599052     DOI: 10.1358/mf.1999.21.8.794835

Source DB:  PubMed          Journal:  Methods Find Exp Clin Pharmacol        ISSN: 0379-0355


  14 in total

1.  Citicoline affects appetite and cortico-limbic responses to images of high-calorie foods.

Authors:  William D S Killgore; Amy J Ross; Toshikazu Kamiya; Yoko Kawada; Perry F Renshaw; Deborah A Yurgelun-Todd
Journal:  Int J Eat Disord       Date:  2010-01       Impact factor: 4.861

Review 2.  The hippocampus and cognitive impairments.

Authors:  E B Arushanyan; E V Beier
Journal:  Neurosci Behav Physiol       Date:  2008-10

Review 3.  Citicoline in addictive disorders: a review of the literature.

Authors:  Nicholas D Wignall; E Sherwood Brown
Journal:  Am J Drug Alcohol Abuse       Date:  2014-06-20       Impact factor: 3.829

4.  CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons.

Authors:  Cecilia Mir; Josep Clotet; Rosa Aledo; Núria Durany; Josep Argemí; Rafael Lozano; Jordi Cervós-Navarro; Núria Casals
Journal:  J Mol Neurosci       Date:  2003-02       Impact factor: 3.444

Review 5.  Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

6.  Death is associated with complement C3 depletion in cerebrospinal fluid of patients with pneumococcal meningitis.

Authors:  U R Goonetilleke; M Scarborough; S A Ward; S Hussain; A Kadioglu; S B Gordon
Journal:  mBio       Date:  2012-03-13       Impact factor: 7.867

Review 7.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

8.  Role of Citicoline in an in vitro AMD model.

Authors:  Sonali Nashine; M Cristina Kenney
Journal:  Aging (Albany NY)       Date:  2020-05-29       Impact factor: 5.682

9.  Could proteomic research deliver the next generation of treatments for pneumococcal meningitis?

Authors:  U R Goonetilleke; S A Ward; S B Gordon
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-05-27

Review 10.  Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives.

Authors:  Gloria Roberti; Lucia Tanga; Manuele Michelessi; Luciano Quaranta; Vincenzo Parisi; Gianluca Manni; Francesco Oddone
Journal:  Int J Mol Sci       Date:  2015-11-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.